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Abstract
Background: The advent of cheap, large scale genotyping has led to widespread adoption of
genetic association mapping as the tool of choice in the search for loci underlying susceptibility to
common complex disease. Whilst simple single locus analysis is relatively trivial to conduct, this is
not true of more complex analysis such as those involving interactions between loci. The
importance of testing for interactions between loci in association analysis has been highlighted in a
number of recent high profile publications.
Results: Genetic Association Interaction Analysis (GAIA) is a web-based application for testing for
statistical interactions between loci. It is based upon the widely used case-control study design for
genetic association analysis and is designed so that non-specialists may routinely apply tests for
interaction. GAIA allows simple testing of both additive and additive plus dominance interaction
models and includes permutation testing to appropriately correct for multiple testing. The
application will find use both in candidate gene based studies and in genome-wide association
studies. For large scale studies GAIA includes a screening approach which prioritizes loci (based on
the significance of main effects at one or both loci) for further interaction analysis.
Conclusion: GAIA is available at http://www.bbu.cf.ac.uk/html/research/biostats.htm
Background
Genetic association mapping is one of the primary tools
used to identify loci involved in common complex dis-
ease. Such analyses are typically implemented by testing
for a difference between allele frequencies at a locus in a
population sample of cases and controls. However, such
an approach only considers one locus at a time. Most
common diseases will be genetically complex, with multi-
ple loci contributing to disease susceptibility. Epistasis is
the phenomenon where the phenotypic effect of one
locus changes as a result of the genotype at one or more
other loci. The importance of epistasis has been strongly
emphasised recently [1-3], with the poor replication rate
of human genetic association studies cited as being partly
attributable to the lack of consideration given to epistatic
effects [4,5]. Another recent paper [6] has suggested the
power of large scale studies may be substantially
improved by considering interactions among loci.
Appropriate analysis of population data may be invalua-
ble in identifying loci that exhibit significant interaction
(in the statistical sense). Although analyses which con-
sider interaction terms can be implemented in packages
such as R [7] or STATA (for scripts and further details see
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implement and cannot be readily applied to large num-
bers of genetic markers. Since large volumes of population
data are now being generated in many molecular genetics
laboratories there is an urgent need for applications which
can streamline the data analysis stage of genetic associa-
tion mapping projects. GAIA, a freely available, easy-to-
use web application, allows non-specialist users to rou-
tinely test for interactions.
Methods
Regression model
GAIA uses perl CGI scripts to code the data, with the R
package [7] used for the necessary statistical routines. The
application uses a regression model which allows the user
to test for pairwise locus-locus interactions between genes.
For the case-control data sets typically employed, this uti-
lizes the logistic regression model
where p is the probability of each individual being a case,
xi and zi are dummy variables with xi = 1, zi = -0.5 for one
homozygote genotype, xi = 0, zi = 0.5 for the heterozygote
genotypes and xi = -1, zi = -0.5 for the other homozygote
[9]. We assume a diallelic locus such as a single nucleotide
polymorphism (SNP). µ corresponds to the mean effect.
The terms a1, d1, a2, d2 represent the parameters corre-
sponding to the additive and dominance effects at the two
SNPs (i.e. the main effects). Similarly, iaa, iad, ida, idd repre-
sent the epistatic interaction effects.
Implemented tests
GAIA allows an "additive plus dominance" 4 degree of
freedom (df) test of interaction in which a model with the
terms iaa, iad, ida, idd is compared with one without them; in
GAIA this is referred to as the "interaction only" p-value.
The "interaction only" p-value tests the significance of the
interaction model terms over and above any main effects.
Also implemented is an 8 df test of overall significance
(model with all terms compared with model with only µ
fitted); in GAIA this is referred to as the "overall" p-value.
The "overall" p-value tests the significance of all terms in
the model (i.e. the joint significance of both main effects
and interaction effects). By dropping dominance terms
GAIA can perform an "additive only" 1 df interaction test
(i.e. a model with a1x1, a2x2 and iaa versus a model with
a1x1 and a2x2) and a 3 df overall significance test (i.e. a
model with a1x1, a2x2 and iaa versus a model with only µ).
The significance of the relevant model terms can be evalu-
ated by comparing twice the log-likelihood difference
between models with a χ2 distribution. Alternatively, per-
mutation based tests can be applied (see below). The par-
simonious models with only additive effects will be
powerful when dominance effects are moderate or small.
For markers with small minor allele frequencies it may
not be possible to fit all the interaction terms with the
additive plus dominance model; this results because some
of the relevant locus-locus genotype are not present in the
data. In general, with n and m model terms for each
marker, the interaction test will have n × m df. This means
that interaction tests involving multiallelic markers and/
or haplotypes will have large numbers of degrees of free-
dom. Tests based on large df are unlikely to powerful for
general screening of genes and hence are not imple-
mented in the web application. Multiallelic markers can
of course be downcoded to two alleles for use in the appli-
cation. GAIA is intended for use with genes that are in
linkage equilibrium (for example genes far apart on the
same chromosome or on different chromosomes). For
nearby gene pairs the application still gives valid results
but this sort of data is probably better dealt with by con-
structing haplotype based tests of association.
Input format
GAIA has a flexible input format allowing either i) the
data for both genes to be coded in a single file, or ii) sep-
arate data files for each gene; files are automatically
merged based on matching values in the first field. The
input file is required to be in "Linkage" format, which is
essentially the de facto standard for coding genetic data
[10]. The user then specifies the marker(s) of interest and
the analysis options required. In addition to additive only
and additive plus dominance interaction models the pro-
gram can output standard allelic (i.e. additive only) and
genotypic (i.e. additive plus dominance) tests for each
SNP singly.
Permutation testing
Although Bonferroni corrections can be readily applied
for independent statistical tests, markers within the same
gene are likely to have correlated allele frequencies. We
hence apply a permutation procedure which appropri-
ately takes into account this non-independence [11]. The
two different possible significance tests require different
permutation tests. The test for the significance of the inter-
action terms (over and above the main effects) is per-
formed by permuting the interaction model terms, with
the main effects and disease status remaining as in the
original data set. The test for overall significance is per-
formed by permuting the status variable and keeping the
other model terms fixed. The possible permutation tests
are discussed further in a paper by Carlborg and Anders-
son [12]. The relevant test statistics are recalculated a large
number of times, with the appropriate permutation pro-
cedure applied each time. By sorting the resultant p-values
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pendence of the two possible interaction tests.
In the simple case where the permutation test is con-
ducted on a single marker, the permutation p-values
should be very similar to the (asymptotic) p-values from
a χ2 distribution on the appropriate degrees of freedom.
We therefore validated the "interaction only" test by com-
paring the asymptotic p-value (from a  distribu-
tion)with the permutation p-value calculated for the
"additiveonly" 1 df "interaction only" test (i.e. a model
with a1x1, a2x2 and iaa versus a model with a1x1 and a2x2).
The test was applied to a set of 135 cases and 289 controls
typed for a single SNP. The asymptotic p-value for the
interaction test was 0.01169. With 200000 permutations
the permutation based p-value was 0.01171 (approximate
95% confidence interval for stochastic error in this esti-
mate (0.01122,0.01219)). This indicates that permuting
the interaction terms (i.e iaa in the additive case) and recal-
culating yields an appropriate p-value. In practice, such a
large number of permutations would not typically be nec-
essary. In the more complicated case where multiple
markers are used, we would hence expect the permutation
procedure to provide p-values that appropriately account
for the multiple tests done.
Results
Candidate gene example
We used GAIA to analyse data from a case control study of
the candidate gene GENEX in schizophrenia (real gene
name suppressed). We wanted to test for interactions
between GENEX and the gene GENEXInteractingProtein
(which are on different chromosomes). There was a clear
biological motivation for testing for interaction between
SNPs in these two genes. We used GAIA to test 20 SNPs in
GENEX for interactions with a SNP in GENEXInteracting-
Protein. 673 cases and 716 controls were available. The
additive "interaction only" test was utilised. Applying
GAIA to the available case control data yielded evidence
for an interaction, with the p-value of 0.00033 for the sig-
nificance of the interaction (over and above the main
effects) for a marker in GENEX. A few of the 20 SNPs in
GENEX were in strong linkage disequilibrium so applying
a Bonferroni correction for the multiple markers tested
would be overly conservative (Bonferroni corrected p-
value was 0.0066). Applying the web applications permu-
tation correction for multiple testing yielded a p-value of
0.0058. In a test run on this data set, 10000 permutations
took  10 hours with GAIA. It is interesting to note that,
when we examined GENEX and GENEX-InteractingPro-
tein, we did not find significant main effects for either of
the two SNPs that were found to interact (although we did
find significant main effects for some of the other SNPs in
GENEX).
Large scale analysis
With approximately 30000 human genes and hence
potentially   45 million pairwise interactions,
a large number of epistatic tests can be performed. In prac-
tice, the total number of tests done will be even greater
than this because of the need to type multiple SNPs per
gene. To reduce the multiple testing burden we suggest
initially testing for interactions between candidate genes,
as in the schizophrenia example above. We also recom-
mend that, in the first instance, only pairs of SNPs with
some evidence for main effects (at each SNP separately)
are tested for interaction. Whilst it is possible that SNPs
with smaller marginal effects (i.e. the effect of the SNP on
its own) are important in higher order interaction terms,
it makes sense to first test SNPs with significant main
effects (see also screening approach below). Further dis-
cussion of interaction models with no main effects is
given in [6,13,14].
In a wider, chromosome- or genome-wide context, there
may also be value in applying interaction analysis, with
the improved power outweighing the cost of the multiple-
testing correction [6]. For large scale data GAIA can imple-
ment a screening approach. Loci are screened on a SNP by
SNP basis with SNPs reaching a nominal level of signifi-
cance (p < 0.05 for the additive single marker test) fol-
lowed through to a secondary stage. The user can then
apply one of the following approaches
1. test for interactions between the nominally significant
SNPs
2. test for interactions between the nominally significant
SNPs and all of the SNPs in the original data set
To perform this procedure in GAIA, the web application is
first used to generate a file containing the nominally sig-
nificant SNPs. This file is then either i) reloaded into GAIA
in both input boxes (first approach), or ii) reloaded into
one input box with the original data file loaded into the
other input box (second approach). GAIA is then run as
usual on the relevant subset of SNPs. Although both the
"interaction only" and the "overall" test can be applied
here, recent research suggests that utilising the "overall"
test may be particularly fruitful here (see also discussion
section). More detailed instructions on performing the
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less intensive and requires fewer tests, we would recom-
mend the second of the two approaches. This is because
the increase in the number of tests is modest and it is
rather restrictive to only test pairs where both have main
effects. In many realistic scenarios where epistatic effects
are important, the main effect of at least one of the inter-
acting loci would not be significant [6] and hence should
ideally not be discarded in the screening stage.
To test the feasibility of applying GAIA to a large number
of markers we applied the screening approach to a set of
600 SNPs typed in 135 cases and 289 controls across chro-
mosome 10. Testing for all possible pairwise combina-
tions would involve 600 × 599/2 = 179700 interaction
tests. Whilst not impossible, this number of tests on these
data would take  15 hours computing time with GAIA.
Applying the first and second screening approaches above
reduced the number of interaction tests to  = 406
and 600 × 29 -  = 16965, respectively (29 of the
600 SNPs were significant at the 5% level). 16965 interac-
tion tests (additive terms only model) took 80 mins to
run, indicating that the screening approach allows large
numbers of markers to be readily tested with GAIA.
With large numbers of markers the applications capacity
for permutation analysis is limited. However, since a rela-
tively small proportion of such loci will be correlated, the
Bonferroni correction will not be overly conservative
when applied to large numbers of markers (cf. situation
with a small number of markers within a candidiate gene
where LD may be strong and hence the Bonferroni correc-
tion rather conservative).
Discussion
GAIA allows researchers to apply two different tests. One
test, the "interaction only" test, considers the significance
of the interaction terms on their own (over and above
main effects). The other test, the "overall" test, considers
the overall significance of both the main (or marginal)
effects and the interaction effects together (i.e. a model
with the terms a1, d1, a2, d2, iaa, iad, ida, idd compared with a
model without them). The tests will be useful in different
situations. The "interaction only" test will be most useful
in candidate gene studies; for example in the schizophre-
nia data described here, there was evidence for statistical
interaction between two biologically related genes. The
"overall" test will be useful as a replacement for associa-
tion testing of large numbers of loci singly. The "overall"
test was discussed in this context by Marchini et al [6];
they show that models with interaction terms can be more
powerful than simpler models which ignore interaction.
Power improvements were shown both for a brute force
approach which tested all possible interactions and an
approach which screened loci for nominal significance
[6]. In many realistic scenarios they show that the
improved power outweighs the cost of the multiple-test-
ing correction. Essentially, the increase in significance
when fitting the "correct" model scales better with sample
size than magnitude of multiple testing correction [3].
Models similar to those described by Marchini et al were
considered recently by Millstein et al [15]. Millstein et al
apply a slightly different set of sequential tests. Tests are
done by selectively conditioning on previous results from
single locus tests [15]. Another approach which addressed
some of the same issues (but not in a human genetics con-
text) is Carlborg and Andersson [12]. In GAIA the imple-
mented approach for sequential testing involves applying
the screening approach described in the previous section.
Consider the 600 SNP example outlined earlier. With 600
SNPs, one would expect to find approximately 30 SNPs
that were significant on their own (at a nominal 5% sig-
nificance level and assuming only a small proportion of
loci actually influence disease risk). A useful screen (simi-
lar to that described in strategy III from Marchini et al)
with the "overall" test would therefore be to compute the
600 × 30 -  = 17535 possible overall tests
(assuming we test the  30 SNPs against all 600). To
maintain an appropriate type I error one needs to correct
for multiple tests done. In this example if we take the best
p-value from any test done, we would (Bonferroni) cor-
rect for 17535+600 = 18135 tests. A detailed comparison
of the different approaches described for large scale asso-
ciation analysis with interaction [6,12,15] would be an
interesting area for further study.
Logistic regression based interaction has been utilised by
a various authors [6,9,15]. Although this method can be
applied using standard statistical packages, GAIA facili-
tates simple application of the method with the added
advantage of permutation analysis and simple screening
for inclusion of SNPs in the interaction test. A non-para-
metric alternative to parametric analyses such as logistic
regression is Multifactor Dimensionality Reduction
(MDR) [16]. The MDR approach avoids specifying a par-
ticular model for the interactions and instead bases its
inferences on sets of "high" and "low" risk multilocus gen-
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many realistic models of interaction, the MDR approach
has been shown to be less powerful than approaches
based on logistic regression [15].
GAIA does not currently accommodate family-based asso-
ciation design data. Tests analogous to the family based
Transmission Distortion Test (TDT, [17] and refinements)
can be conducted through the use of conditional logistic
regression [18] and this accommodates the linear mode-
ling of interactions. However, such methods are most
powerful when there are informative transmissions from
heterozygote parents and the use of highly polymorphic
markers (with high heterozygosity) undesirably leads to
large numbers of degrees of freedom in the tests for inter-
actions described above. This, combined with the larger
sample sizes usually available, means that case-control
design is likely to be most suitable for interaction analysis.
It is important to differentiate between biological epistasis
(e.g. where two or more genes are involved in the same
biological pathway and are jointly responsible for the end
phenotype) and statistical epistasis (i.e. the deviation of
the terms iaa, iad, ida, idd from zero in the linear model
stated above). Biological epistasis occurs at the individual
level whereas statistical epistasis necessarily is based upon
populations. There is no direct relationship between these
two definitions of epistasis and the existence of a number
of possible parameterizations of the penetrances (param-
eters that define the genotype-phenotype relationship for
binary traits) mean that the significance of the interaction
terms maybe scale dependent [9]. In GAIA we utilise the
log odds of the penetrance; this function is widely used in
epidemiological studies and yields results comparable to
those obtained from standard contingency tables when
applied to single SNPs. For further discussion of the bio-
logical/statistical epistasis issue see [9,14].
Conclusion
GAIA allows non-specialists access to interaction analysis
of genetic association data. In our lab the application has
allowed such users to routinely screen the candidate genes
they are currently interested in against a set of established
loci for a variety of genetically complex psychiatric dis-
eases. By combining appropriate biological information
on the genes underlying the detected statistical interac-
tions, GAIA users should be able to better understand the
aetiology of the disease under study. GAIA also allows
interaction analysis to be applied on a larger scale. A prac-
tical screening facility which discards loci not showing
main effects at either locus is provided in GAIA to make
large scale analysis tractable.
Availability and requirements
GAIA is accessible via http://www.bbu.cf.ac.uk/html/
research/biostats.htm and is freely available for use by
academics and non-academics. The source code for GAIA
(perl and R) is available from the above URL. GAIA cur-
rently runs on 2 separate Intel based PCs (both accessible
via the above URL).
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